The 39-year-old, best known for playing Buffy the Vampire Slayer's younger sister Dawn Summers was found dead at her home in ...

Scholar Rock Holding Corporation's apitegromab shows promise for SMA treatment, aims for 2025 launch. Click for my updated ...

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce ...

Earlier in March, Beam announced positive initial safety and efficacy data from the trial: a single infusion of BEAM-302 ... developing alternatives to glucagon-like peptide 1 (GLP-1) therapies.

The so-called 'hybrid closed-loop' system comprises a blood glucose sensor, the MiniMed 670G insulin pump and an infusion patch ... those that also administer glucagon. Beta Bionics' iLet ...

The platform allows for the subcutaneous administration of drugs – between skin and muscle for slow and sustained absorption – that are typically given as an intravenous (IV) infusion ... GIP, and ...

Lilly trumpeted positive topline results from ACHIEVE-1 (NCT05971940) showing orforglipron to have met the trial’s primary ...

CuraTeQ Biologics s.r.o., announced that the CHMP of the European Medicines Agency has adopted a positive opinion recommending marketing authorisation of Dazublys®, its trastuzumab biosimilar, for the ...

Is DRIP or auto-balance a better way to navigate stock volatility? I don’t think you could go wrong by embracing either DRIP (dividend reinvestment plan) or auto-balance (dividends to cash for ...